Trump’s Pharma Tariffs Spare Richest Drugmakers

The New York TimesFriday, September 26, 2025 at 4:44:36 PM
Trump’s Pharma Tariffs Spare Richest Drugmakers
Recent developments reveal that President Trump's tariffs on pharmaceuticals are favoring the wealthiest drugmakers, raising concerns about the impact on healthcare costs for everyday Americans. This situation highlights the ongoing debate over drug pricing and access to essential medications, as many fear that the burden of these tariffs will ultimately fall on consumers rather than the companies profiting from them.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Big Pharma Unfazed by Trump Tariffs, But Small Biotechs Face Vulnerability
NeutralFinancial Markets
The pharmaceutical industry is showing resilience in the face of potential tariffs proposed by Trump, with major companies committing to invest billions in domestic manufacturing. However, smaller biotech firms may find themselves more vulnerable to these economic shifts. This situation highlights the contrasting capabilities of large corporations versus smaller entities in navigating financial challenges, which could impact innovation and competition in the healthcare sector.
Big Pharma Unfazed by Trump Tariffs, But Small Biotechs Face Vulnerability
NeutralFinancial Markets
The pharmaceutical industry is showing resilience in the face of potential tariffs proposed by Trump, with major companies committing to invest billions in domestic manufacturing. However, smaller biotech firms may find themselves more vulnerable to these economic shifts. This situation highlights the contrasting capabilities of large corporations versus smaller entities in navigating financial challenges, which could impact innovation and competition in the healthcare sector.
Big Pharma Unfazed by Trump Tariffs, But Small Biotechs Face Vulnerability
NeutralFinancial Markets
The pharmaceutical industry is showing resilience in the face of potential tariffs proposed by Trump, with major companies committing to invest billions in domestic manufacturing. However, smaller biotech firms may find themselves more vulnerable to these economic shifts. This situation highlights the contrasting capabilities of large corporations versus smaller entities in navigating financial challenges, which could impact innovation and competition in the healthcare sector.
Comey indictment escalates Trump’s campaign to chill opposition
NegativeFinancial Markets
The recent indictment of James Comey has intensified former President Trump's efforts to suppress dissent within the political landscape. This development is significant as it raises concerns about the implications for free speech and the integrity of political discourse in the United States. Many view this as a strategic move by Trump to undermine his critics and consolidate power, which could have lasting effects on the democratic process.
Comey indictment escalates Trump’s campaign to chill opposition
NegativeFinancial Markets
The recent indictment of James Comey has intensified former President Trump's efforts to suppress dissent within the political landscape. This development is significant as it raises concerns about the implications for free speech and the integrity of political discourse in the United States. Many view this as a strategic move by Trump to undermine his critics and consolidate power, which could have lasting effects on the democratic process.
Comey indictment escalates Trump’s campaign to chill opposition
NegativeFinancial Markets
The recent indictment of James Comey has intensified former President Trump's efforts to suppress dissent within the political landscape. This development is significant as it raises concerns about the implications for free speech and the integrity of political discourse in the United States. Many view this as a strategic move by Trump to undermine his critics and consolidate power, which could have lasting effects on the democratic process.
Lawyers cite Trump autism warning in push to revive Tylenol lawsuits
NeutralFinancial Markets
Lawyers are leveraging President Trump's recent comments linking the active ingredient in Tylenol to developmental disorders to revive lawsuits that were previously dismissed. This development is significant as it could reopen discussions about the safety of widely used medications and their potential impact on children's health, prompting a closer examination of pharmaceutical regulations.
Lawyers cite Trump autism warning in push to revive Tylenol lawsuits
NeutralFinancial Markets
Lawyers are leveraging President Trump's recent comments linking the active ingredient in Tylenol to developmental disorders to revive lawsuits that were previously dismissed. This development is significant as it could reopen discussions about the safety of widely used medications and their potential impact on children's health, prompting a closer examination of pharmaceutical regulations.
Lawyers cite Trump autism warning in push to revive Tylenol lawsuits
NeutralFinancial Markets
Lawyers are leveraging President Trump's recent comments linking the active ingredient in Tylenol to developmental disorders to revive lawsuits that were previously dismissed. This development is significant as it could reopen discussions about the safety of widely used medications and their potential impact on children's health, prompting a closer examination of pharmaceutical regulations.
Britain would face 100% tariff on pharmaceuticals under latest Trump plan, sources say
NegativeFinancial Markets
Recent reports indicate that under a new plan proposed by former President Trump, Britain could face a staggering 100% tariff on pharmaceuticals. This development raises significant concerns for the UK's healthcare system and its ability to access essential medications. Such tariffs could lead to increased costs for patients and strain the already challenged NHS, making it a critical issue for public health and international trade relations.
Britain would face 100% tariff on pharmaceuticals under latest Trump plan, sources say
NegativeFinancial Markets
Recent reports indicate that under a new plan proposed by former President Trump, Britain could face a staggering 100% tariff on pharmaceuticals. This development raises significant concerns for the UK's healthcare system and its ability to access essential medications. Such tariffs could lead to increased costs for patients and strain the already challenged NHS, making it a critical issue for public health and international trade relations.
Britain would face 100% tariff on pharmaceuticals under latest Trump plan, sources say
NegativeFinancial Markets
Recent reports indicate that under a new plan proposed by former President Trump, Britain could face a staggering 100% tariff on pharmaceuticals. This development raises significant concerns for the UK's healthcare system and its ability to access essential medications. Such tariffs could lead to increased costs for patients and strain the already challenged NHS, making it a critical issue for public health and international trade relations.
Latest from Financial Markets
Erin Burnett Net Worth 2025: CNN Salary, Career, and Family
PositiveFinancial Markets
Erin Burnett's net worth in 2025 reflects her successful career as a prominent CNN anchor and journalist. Known for her insightful reporting and engaging style, Burnett has made a significant impact in the media landscape. Her salary and financial success highlight the value of experienced journalists in today's news environment, making her a role model for aspiring reporters. This article not only sheds light on her financial achievements but also emphasizes the importance of quality journalism in informing the public.
Wolf Blitzer Net Worth 2025: CNN Salary, Career, Family and Recent News
PositiveFinancial Markets
Wolf Blitzer's net worth is projected to grow significantly by 2025, reflecting his long-standing career at CNN and his influence in the media industry. Known for his insightful reporting and engaging presence, Blitzer has become a household name, making his financial success a topic of interest. This matters because it highlights the value of experienced journalists in today's fast-paced news environment, and it showcases how media personalities can leverage their careers for financial stability.
Anderson Cooper Net Worth 2025: CNN Salary, Vanderbilt Legacy, and Family Life
PositiveFinancial Markets
Anderson Cooper's net worth in 2025 reflects his successful career at CNN and his notable Vanderbilt family legacy. As a prominent journalist, Cooper has made a significant impact in the media landscape, and his financial success is a testament to his hard work and dedication. This article not only highlights his earnings but also delves into his family life, showcasing the balance he maintains between his professional and personal commitments. Understanding Cooper's journey is inspiring for many, as it illustrates the potential for success in the competitive world of journalism.
Los Azules copper project approved for Argentina's investment incentive regime
PositiveFinancial Markets
The Los Azules copper project has received approval for Argentina's investment incentive regime, marking a significant step forward for the mining sector in the country. This approval is crucial as it not only boosts investor confidence but also promises to enhance economic growth and job creation in the region. With the global demand for copper on the rise, this project positions Argentina as a key player in the mining industry, potentially attracting further investments and development.
Tricolor Crisis Managers Locked Out After Bankruptcy
NegativeFinancial Markets
Tricolor's sudden bankruptcy filing has raised serious concerns, especially with US prosecutors investigating potential fraud allegations against the company. Just a week after these shocking claims surfaced, a team from Vervent discovered the Tricolor headquarters in chaos and was subsequently locked out. This situation highlights the growing scrutiny on corporate practices and the importance of transparency in business operations, making it a significant story for investors and consumers alike.
Electronic Arts nears roughly $50 billion deal to go private, WSJ reports
PositiveFinancial Markets
Electronic Arts is reportedly close to finalizing a deal worth around $50 billion to go private, according to the Wall Street Journal. This move could significantly reshape the gaming industry, allowing EA to focus on long-term strategies without the pressures of public market scrutiny. Such a transition may lead to innovative game development and enhanced player experiences, making it a noteworthy development for gamers and investors alike.